Phocas Financial Corp. Acadia Pharmaceuticals Inc Transaction History
Phocas Financial Corp.
- $749 Billion
- Q4 2024
A detailed history of Phocas Financial Corp. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Phocas Financial Corp. holds 107,811 shares of ACAD stock, worth $1.81 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
107,811
Previous 16,379
558.23%
Holding current value
$1.81 Million
Previous $301 Million
558.12%
% of portfolio
0.26%
Previous 0.22%
Shares
7 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$719 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$234 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$202 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$146 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$122 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.71B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...